News Kite files CAR-T therapy in EU, ahead of Novartis rival Kite eyes possible CAR-T launch next year.
News Oxford BioMedica signs $100m CAR-T deal with Novartis UK firm to supply viruses to generate CAR-T therapies
News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
